Report Publication Announcement • Jan 2, 2017
Report Publication Announcement
Open in ViewerOpens in native device viewer
Paris, France and Cambridge, MA, USA, January 2, 2017 – Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today its schedule for the publication of financial information for 2017.
| Event | Date * |
|---|---|
| 2016 Fourth-Quarter Sales | January 24, 2017 |
| 2016 Full-Year Results | March 23, 2017 |
| 2017 First-Quarter Sales | April 25, 2017 |
| Annual General Meeting | May 3, 2017 |
| 2017 First-Half Sales | July 25, 2017 |
| 2017 First-Half Results | September 20, 2017 |
| 2017 Third-Quarter Sales | October 24, 2017 |
* Subject to modification. Press releases are published after market closes.
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico.
For more information on Mauna Kea Technologies, visit www.maunakeatech.com
| Mauna Kea Technologies | |
|---|---|
| Benoit Jacheet | |
| CFO | |
| [email protected] | |
United States Zack Kubow / Lee Roth The Ruth Group 646-536-7020 / 7012 [email protected] / [email protected]
U.S. Media
Christopher Hippolyte The Ruth Group 646-536-7023 [email protected] France and Europe
NewCap - Investor Relations Florent Alba +33 (0)1 44 71 94 94 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.